Qiagen NV (WBO:QGE2) 3-Year EPS without NRI Growth Rate : 0.20% (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV 3-Year EPS without NRI Growth Rate?

Qiagen NV's EPS without NRI for the three months ended in Dec. 2023 was €0.52.

During the past 12 months, Qiagen NV's average EPS without NRI Growth Rate was 3.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 0.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 19.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 24.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Qiagen NV was 69.50% per year. The lowest was -21.50% per year. And the median was 18.90% per year.

Competitive Comparison of Qiagen NV's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Qiagen NV's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qiagen NV's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Qiagen NV's 3-Year EPS without NRI Growth Rate falls into.

Qiagen NV 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Qiagen NV (WBO:QGE2) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Qiagen NV 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Qiagen NV's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (WBO:QGE2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (WBO:QGE2) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

QGEN:USA 1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Qiagen NV (WBO:QGE2) Headlines

No Headlines